Pacific Biosciences of California Inc.

News & Events

Press Releases

In The Media

1. Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date

   PR Newswire JUN 2, 2025 10:00 AM EDT
   Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Stu...
   READ ARTICLE

2. PacBio to Present at Upcoming Investor Conferences

   GlobeNewswire MAY 28, 2025 9:00 AM EDT
   MENLO PARK, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer o...
   READ ARTICLE

3. PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene

   GlobeNewswire MAY 22, 2025 9:05 AM EDT
   MENLO PARK, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of...
   READ ARTICLE

4. PacBio Board Independent Investigation Concludes Allegations Unsubstantiated

   GlobeNewswire MAY 12, 2025 10:56 AM EDT
   MENLO PARK, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced that t...
   READ ARTICLE

5. PacBio Announces First Quarter 2025 Financial Results

   GlobeNewswire MAY 8, 2025 4:15 PM EDT
   MENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financ...
   READ ARTICLE

6. First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand

   GlobeNewswire MAY 5, 2025 9:05 AM EDT
   MENLO PARK, Calif. and BANGKOK, May 05, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB) a lea...
   READ ARTICLE

7. PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry

   GlobeNewswire APR 28, 2025 9:05 AM EDT
   MENLO PARK, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading provider ...
   READ ARTICLE

8. Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa

   GlobeNewswire APR 22, 2025 9:05 AM EDT
   MENLO PARK, Calif. and GENEVA, Switzerland , April 22, 2025 (GLOBE NEWSWIRE) -- The Davos Alzheim...
   READ ARTICLE

9. PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million

   GlobeNewswire APR 9, 2025 9:05 AM EDT
   Implements Plan to Reduce Annualized Operating Expense Run Rate by $45 Million to $50 M...
   READ ARTICLE

10. PacBio Grants Equity Incentive Award to New Employee

    GlobeNewswire APR 4, 2025 7:45 PM EDT
    MENLO PARK, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider ...
    READ ARTICLE